Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7581965 | 7943131 | F | 7581965-6 | 20110420 | 20110621 | 20110630 | EXP | US-BIOGENIDEC-2011BI016820 | BIOGEN IDEC INC. | 38 | YR | M | Y | 20110630 | MD | UNITED STATES |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
7581965 | 1016899633 | PS | TYSABRI | 1 | INTRAVENOUS |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
7581965 | 1016899633 | MULTIPLE SCLEROSIS |
Outcome of event
Event ID | OUTC COD |
---|---|
7581965 | DE |
Reactions reported
Event ID | PT |
---|---|
7581965 | DEATH |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
7581965 | 1016899633 | 20090216 | 20101105 |